Dabur India forecasts low to single-digit Q3 revenue growth
Dabur India, an ayurvedic and natural healthcare company, forecasts a low to mid-single-digit revenue growth for the third quarter ending December 31 due.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Dabur India, an ayurvedic and natural healthcare company, forecasts a low to mid-single-digit revenue growth for the third quarter ending December 31 due.
Investigators from India's Director General of Trade Remedies have started an anti-dumping probe into vitamin A palmitate imports from China, the EU and.
There is a predominance of Omicron BA. 5.2 and BF.7 Covid-19 lineages, accounting for 97.5% of all local infections in China, according to.
More than 50 million Indians suffer from fungal diseases and 10% belong to the potentially dangerous mould infections, according to researchers from New.
PeptiDream to collaborate with Merck and Eli Lilly for the discovery and development of Novel Peptide Drug Conjugates
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
China tore on to Covid-19 travel restrictions imposed on travellers from Beijing by the US and EU nations and stated it will take.
A coin-sized implant device has the potential to treat Type 1 diabetes, researchers claim.
A nanoparticle treatment has "cured" mice that had a genetic arthritis condition, according to Scripps Research, a nonprofit US medical research institution.
Bharat Biotech, an Indian developer of vaccines for infectious diseases, will roll out its nasal Covid-19 vaccine for patients above 18 years in.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com